Roemenië - Roemeens - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

mylan laboratories s.a.s. - olanda - betahistinum - compr. - 24mg - med. pentru tratamentul tulburarilor de echilibru medicamente antivertiginoase

Roemenië - Roemeens - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

mylan laboratories s.a.s. - franta - betahistinum - compr. - 8mg - med. pentru tratamentul tulburarilor de echilibru medicamente antivertiginoase

Roemenië - Roemeens - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

famar health care services madrid, s.a.u. - spania - propafenonum - sol. inj. - 70mg/20ml - antiaritmice clasa i si iii antiaritmice clasa ic

Roemenië - Roemeens - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

abbott biologicals b.v. - olanda - dydrogesteronum - compr. film. - 10mg - progestative derivati de pregnadiona

Roemenië - Roemeens - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

abbvie s.r.l. - italia - ibuprofenum - susp. orala - 20mg/ml - antiinflamatoare si antireumatice nesteroidiene derivati de acid propionic

Roemenië - Roemeens - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

abbott biologicals b.v. - olanda - lactulosum - sol. orala - 667mg/ml - laxative laxative osmotice

Roemenië - Roemeens - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

abbott laboratories gmbh - germania - pancreatinum - caps. gastrorez. - 300mg - enzime digestive preparate enzimatice

Roemenië - Roemeens - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

abbott laboratories gmbh - germania - pancreatinum - caps. gastrorez. - 420mg - enzime digestive preparate enzimatice

Europese Unie - Roemeens - EMA (European Medicines Agency)

viatris limited - pirfenidonă - idiopathic pulmonary fibrosis; lung diseases; respiratory tract diseases - imunosupresoare - pirfenidone viatris is indicated in adults for the treatment of mild to moderate idiopathic pulmonary fibrosis (ipf).

Europese Unie - Roemeens - EMA (European Medicines Agency)

viatris limited - dapagliflozin - diabetes mellitus, type 2; heart failure, systolic; heart failure; renal insufficiency, chronic - medicamente utilizate în diabet - type 2 diabetes mellitusdapagliflozin viatris is indicated in adults and children aged 10 years and above for the treatment of insufficiently controlled type 2 diabetes mellitus as an adjunct to diet and exercise- as monotherapy when metformin is considered inappropriate due to intolerance. - in addition to other medicinal products for the treatment of type 2 diabetes. for study results with respect to combination of therapies, effects on glycaemic control, cardiovascular and renal events, and the populations studied, see sections 4. 4, 4. 5 și 5. heart failuredapagliflozin viatris is indicated in adults for the treatment of symptomatic chronic heart failure with reduced ejection fraction. chronic kidney diseasedapagliflozin viatris is indicated in adults for the treatment of chronic kidney disease.